Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It would be nice if the CEO reasserted the intention to deliver dividends

to shareholders when future revenues arrive.

I realize that he is a lawyer and that lawyers are inherently adverse to making statements of any kind, however since one of the BoD members has reportedly stated such intent, it would at least be somewhat reassuring.

The lack of communication from the company is, as has been stated many times here, quite frustrating. The company is the electrical equivalent of a diode.

GLTA

Share
New Message
Please login to post a reply